Company Data

Virpax Pharmaceuticals Inc.

Advanced Market Data

Ticker

VRPX

Current Price

$0.8299 5.37%

Market Cap

$9.7M

Price Target

Refer to Report

Volume

25.6K

52wk Range

$0.7639 - $5.62

Advanced Market Data

Overview

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Other Considerations

Baudax Bio Inc.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Baudax Bio Inc.

Baudax Bio Inc.

BXRX (Nasdaq)

$0.1488

$0.14(6.29%)

3.0M

685.1K

$0.131 - $14.7

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Imugene Ltd.

IUGNF (OTO)

$0.13

$0.15(-13.33%)

828.1M

10.7K

$0.0837 - $0.404

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

PsyBio Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

PsyBio Therapeutics

PsyBio Therapeutics

PSYBF (OTO)

$0.03355

$0.04(-12.86%)

3.7M

2.4K

$0.029 - $0.3192

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Axcella Therapeutics

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Axcella Therapeutics

Axcella Therapeutics

AXLA (Nasdaq)

$0.87

$0.83(4.69%)

31.7M

32.4K

$0.7006 - $3.04

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data

Psybio Therapeutics Corp.

Company

Ticker

Price

Previous

Mkt Cap

Volume

52wk Range

Psybio Therapeutics Corp.

Psybio Therapeutics Corp.

PSYB:CA (CDX)

$0.055

6.1M

97.7K

$0.04 - $0.375

Fundamental Analysis:

Rating: Log in to view

Advanced Market Data